Systemic Inflammatory Markers as a Predictors of Response to Crizotinib in Patients with ALK-Positive Non-Small-Cell Lung Cancer


Bilici A., Olmez O. F. , GÜRSOY P., Cubukcu E., Yildiz O., Sakin A. , ...Daha Fazla

JOURNAL OF THORACIC ONCOLOGY, cilt.14, sa.10, 2019 (SCI İndekslerine Giren Dergi) identifier